Simpson Thacher represented Acelity L.P. Inc. (“Acelity”) in connection with the Rule 144A and Regulation S offering of $400 million aggregate principal amount of 7.875% first lien senior secured notes due 2021 by Kinetic Concepts, Inc. and KCI USA, Inc., Acelity’s wholly owned subsidiaries. Acelity intends to use the proceeds from the offering (i) to repay all amounts outstanding under Acelity’s Senior Term E-2 Credit Facility due November 4, 2016, together with accrued interest, (ii) to pay fees and expenses related to the repayment of the Senior Term E-2 Credit Facility and the offering and (iii) for general corporate purposes.
Acelity is a leading global medical technology company committed to the development and commercialization of advanced wound care and regenerative medicine solutions.
The Simpson Thacher team included Kenneth Wallach, Sunny Cheong, Benjamin Heriaud and Izzy Lubarsky (Capital Markets); Gary Mandel and Sophie Staples (Tax); Brian Robbins, Jeannine McSweeney, Joo Hyun Lee and Meaghan Krupa (Executive Compensation and Employee Benefits); and Joia Lee (Public Company Advisory Practice).